Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours.
Paracetamol lacks anti-inflammatory action in rheumatic disorders. However, it is less toxic than the Aspirin and does not produce anemia and liver damage, which sometimes result from the continued use of acetanilide andacetophenetidin. It is also an important intermediate in the manufacture of other pharmaceuticals like theantimalarial amodiaquine.
The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024.
Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D.Thus, as an entrepreneur this project offers an exciting opportunity to you.
Few Indian Major Players are as under
• Ranbaxy (Daichi)
• Dr. Reddy's Labs
• Cipla
• Lupin
• AurobindoPharma
• Sun Pharma
• GlaxoSmithkline
• CadilaPharma
• Nicholas Piramal
• WokhardtLifesciences